Literature DB >> 23406933

The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.

Zhenhong Li1, Zhongliang Ju, Marianne Frieri.   

Abstract

The T-cell immunoglobulin and mucin domain (Tim) gene family is a relatively newly discovered group of molecules with a conserved structure and important immunologic functions. Tim molecules express on many types of immune cells including T cells, B cells, dendritic cells, macrophages, and mast cells that have been shown to be involved in asthma, allergic rhinitis, food allergy, and autoimmunity. Tim-1-Tim-4 interaction promotes Th2 cytokine responses, and blocking this interaction can decrease airway inflammation in asthma and in allergic rhinitis. Tim-3 stimulates mast cells to produce Th2 cytokines, and anti-Tim-3 is able to dampen asthmatic inflammation. The Tim-3 ligand was shown to be greatly enhanced on intestinal epithelial cells in patients with food allergy and Tim-4 may play a role in maintaining oral tolerance and prevention of food allergy. Tim-3 deregulation plays a role in the pathogenesis of multiple sclerosis. Increased Tim-1 expression has been shown in mononuclear cells from systemic lupus erythematosus patients and Tim-3 may be involved in a protective role in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406933     DOI: 10.2500/aap.2013.34.3646

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  34 in total

1.  Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28.

Authors:  Zohreh Koohini; Hadi Hossein-Nataj; Maryam Mobini; Aref Hosseinian-Amiri; Alireza Rafiei; Hossein Asgarian-Omran
Journal:  Clin Rheumatol       Date:  2018-04-07       Impact factor: 2.980

2.  Upregulation of Tim-3 on CD4(+) T cells is associated with Th1/Th2 imbalance in patients with allergic asthma.

Authors:  Fei Tang; Fukun Wang; Liyun An; Xianling Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  [Effect of inhibiting TIM-4 function in Kupffer cells on liver graft rejection in mice].

Authors:  Xue-Qiang Li; Xu-Hong Li; Shi-Gang Duan; Xue-Song Xu; Yi-Ming Liu; Jin-Zheng Li; Jian-Ping Gong; Hao Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

4.  Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model.

Authors:  Siyu Xiao; Jinfeng Liu; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

5.  Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients.

Authors:  Xiangdong Yang; Zhao Hu; Xiyan Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

6.  CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.

Authors:  Yong Zhang; Xiuying Zhang; Yan Xia; Xiao Jia; Hao Li; Yanyan Zhang; Zhen Shao; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng; Yonghai Liu; Guiyun Cui; Ruiguo Dong; Xiaoyu Huang; Tingyan Yu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

7.  Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.

Authors:  Alla Kachko; Maria Isabel Costafreda; Iryna Zubkova; Jerome Jacques; Kazuyo Takeda; Frances Wells; Gerardo Kaplan; Marian E Major
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

8.  Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients.

Authors:  Ling Guo; Xiangdong Yang; Qing Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Clin Exp Med       Date:  2013-11-20       Impact factor: 3.984

9.  Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Authors:  Marsilio Adriani; Petra Nytrova; Cyprien Mbogning; Signe Hässler; Karel Medek; Poul Erik H Jensen; Paul Creeke; Clemens Warnke; Kathleen Ingenhoven; Bernhard Hemmer; Claudia Sievers; Raija Lp Lindberg Gasser; Nicolas Fissolo; Florian Deisenhammer; Zsolt Bocskei; Vincent Mikol; Anna Fogdell-Hahn; Eva Kubala Havrdova; Philippe Broët; Pierre Dönnes; Claudia Mauri; Elizabeth C Jury
Journal:  JCI Insight       Date:  2018-06-07

Review 10.  Tim-3 and Tim-4 as the potential targets for antitumor therapy.

Authors:  Lin Cheng; Zhihua Ruan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.